SCHEMBL2463869

SCHEMBL2463869

CCOc1cc(C=O)cc(Br)c1OCc1cccc(OC2CCCCO2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
LMNA P02545 5/20 0.43
MAPT P10636 3/20 0.43
DHFR P00374 1/20 0.42
KMT2A Q03164 5/20 0.41
HTT P42858 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 4/20 0.39
NPSR1 Q6W5P4 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
CYP1A2 P05177 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
XBP1 P17861 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
POLB P06746 3/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1414014 0.80 ALDH1A1 (0.53) ALDH1A1LMNAMAPTKMT2AHTT
SCHEMBL2513277 0.74 ALDH1A1 (0.55) ALDH1A1LMNAMAPTKMT2AHTT
SCHEMBL11769332 0.73 DHFR (0.56) ALDH1A1MAPTDHFRKMT2AMEN1
SCHEMBL6624255 0.72 DHFR (0.55) ALDH1A1LMNAMAPTDHFRHTT
SCHEMBL29646493 0.72 DHFR (0.46) ALDH1A1DHFRKMT2AL3MBTL1MEN1
SCHEMBL7772717 0.72 DHFR (0.57) ALDH1A1DHFRL3MBTL1SMN1; SMN2KDM4E
SCHEMBL2204157 0.72 DHFR (0.46) ALDH1A1DHFRKMT2AL3MBTL1MEN1
SCHEMBL7234370 0.72 DHFR (0.57) ALDH1A1DHFRL3MBTL1SMN1; SMN2KDM4E
SCHEMBL28518072 0.71 POLB (0.44) ALDH1A1LMNADHFRKMT2AMEN1
SCHEMBL2462874 0.71 KMT2A (0.51) ALDH1A1LMNAMAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022218-B2 Hypogonadism; N-{3-[2-Bromo-4-(3-cyano-2-methyl-5-oxo-7-propyl-1,4,5,6,7,8-hexahydro-quinolin-4-yl)-6-ethoxy-phenoxymethyl]-phenyl}-3,4,5-trimethoxy-benzamide; low molecular weight hormone mimetics; selective Follicle Stimulating Hormone receptor agonists N.V. ORGANON (NL) 2011-09-20 US disclosed
US-20080275042-A1 4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility N.V. ORGANON (NL) 2008-11-06 US disclosed
EP-1881830-B1 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES THE TREATMENT OF INFERTILITY ORGANON NV (NL) 2008-10-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275042-A1 4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility CATSPER1, ABCB11, ACR ALDH1A1 79/4885LMNA 4166/4885MAPT 4655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.